메뉴 건너뛰기




Volumn 11, Issue 3, 2015, Pages 125-140

Immunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives

Author keywords

Adoptive immunotherapy; Adoptive T cell therapy; Allogeneic stem cell transplant; Anti tumor immunity; Antibody therapy; Biomarker; CTLA 4; Cytotoxic T lymphocyte; Dendritic cell; Helper T cell; Immunosuppression; Immunosurveillance; Immunotherapy; Ipilimumab; Macrophage; Metastatic colorectal cancer; Myeloid derived suppressor cell; PD 1 L1; Regulatory T cell; T cell; Vaccine

Indexed keywords

CANCER VACCINE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CHIMERIC ANTIGEN RECEPTOR; CHORIONIC GONADOTROPIN BETA SUBUNIT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; DENDRITIC CELL VACCINE; DIPHTHERIA TOXIN; EPITHELIAL CELL ADHESION MOLECULE; FLT3 LIGAND; GAMMA INTERFERON; GASTRIN 17; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; REACTIVE OXYGEN METABOLITE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

EID: 84929966392     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-015-0269-2     Document Type: Review
Times cited : (24)

References (162)
  • 3
    • 0024390441 scopus 로고
    • Resection of hepatic metastases from colorectal cancer. Biologic perspective
    • PID: 2667471
    • Steele Jr G, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg. 1989;210(2):127–38.
    • (1989) Ann Surg , vol.210 , Issue.2 , pp. 127-138
    • Steele, G.1    Ravikumar, T.S.2
  • 5
    • 33748101222 scopus 로고    scopus 로고
    • Towards a pan-European consensus on the treatment of patients with colorectal liver metastases
    • PID: 16904315
    • Van Cutsem E, Nordlinger B, Adam R, Kohne CH, Pozzo C, Poston G, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer. 2006;42(14):2212–21.
    • (2006) Eur J Cancer , vol.42 , Issue.14 , pp. 2212-2221
    • Van Cutsem, E.1    Nordlinger, B.2    Adam, R.3    Kohne, C.H.4    Pozzo, C.5    Poston, G.6
  • 6
    • 77949519818 scopus 로고    scopus 로고
    • Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer
    • COI: 1:CAS:528:DC%2BC3cXjsF2qs7o%3D, PID: 20233821
    • Kahn KL, Adams JL, Weeks JC, Chrischilles EA, Schrag D, Ayanian JZ, et al. Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA. 2010;303(11):1037–45.
    • (2010) JAMA , vol.303 , Issue.11 , pp. 1037-1045
    • Kahn, K.L.1    Adams, J.L.2    Weeks, J.C.3    Chrischilles, E.A.4    Schrag, D.5    Ayanian, J.Z.6
  • 7
    • 84885764622 scopus 로고    scopus 로고
    • Immunological monitoring of anticancer vaccines in clinical trials
    • PID: 24083085
    • Ogi C, Aruga A. Immunological monitoring of anticancer vaccines in clinical trials. Oncoimmunology. 2013;2(8):e26012.
    • (2013) Oncoimmunology , vol.2 , Issue.8 , pp. 26012
    • Ogi, C.1    Aruga, A.2
  • 8
    • 84255197842 scopus 로고    scopus 로고
    • Cancer immunotherapy comes of age
    • COI: 1:CAS:528:DC%2BC3MXhs1GksLjO, PID: 22193102
    • Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature. 2011;480(7378):480–9.
    • (2011) Nature , vol.480 , Issue.7378 , pp. 480-489
    • Mellman, I.1    Coukos, G.2    Dranoff, G.3
  • 9
    • 0022515473 scopus 로고
    • Lymphocytic infiltration and survival in rectal cancer
    • COI: 1:STN:280:DyaL283ltFersA%3D%3D, PID: 3722412
    • Jass JR. Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol. 1986;39(6):585–9.
    • (1986) J Clin Pathol , vol.39 , Issue.6 , pp. 585-589
    • Jass, J.R.1
  • 10
    • 0014887939 scopus 로고
    • The concept of immunological surveillance
    • COI: 1:STN:280:DyaE3M%2FjvFektg%3D%3D, PID: 4921480
    • Burnet FM. The concept of immunological surveillance. Prog Exp Tumor Res. 1970;13:1–27.
    • (1970) Prog Exp Tumor Res , vol.13
    • Burnet, F.M.1
  • 11
    • 2542430341 scopus 로고    scopus 로고
    • The three Es of cancer immunoediting
    • COI: 1:CAS:528:DC%2BD2cXktlOgs7k%3D, PID: 15032581
    • Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol. 2004;22:329–60.
    • (2004) Annu Rev Immunol , vol.22 , pp. 329-360
    • Dunn, G.P.1    Old, L.J.2    Schreiber, R.D.3
  • 12
    • 9144273838 scopus 로고    scopus 로고
    • Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis
    • COI: 1:STN:280:DC%2BD2crktVKktQ%3D%3D, PID: 15494715
    • Chiba T, Ohtani H, Mizoi T, Naito Y, Sato E, Nagura H, et al. Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br J Cancer. 2004;91(9):1711–7.
    • (2004) Br J Cancer , vol.91 , Issue.9 , pp. 1711-1717
    • Chiba, T.1    Ohtani, H.2    Mizoi, T.3    Naito, Y.4    Sato, E.5    Nagura, H.6
  • 13
    • 29144514645 scopus 로고    scopus 로고
    • Effector memory T cells, early metastasis, and survival in colorectal cancer
    • COI: 1:CAS:528:DC%2BD2MXhtlarsrrE, PID: 16371631
    • Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353(25):2654–66.
    • (2005) N Engl J Med , vol.353 , Issue.25 , pp. 2654-2666
    • Pages, F.1    Berger, A.2    Camus, M.3    Sanchez-Cabo, F.4    Costes, A.5    Molidor, R.6
  • 14
    • 73349142719 scopus 로고    scopus 로고
    • In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer
    • COI: 1:CAS:528:DC%2BC3cXhtVWisL8%3D, PID: 19858404
    • Pages F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol. 2009;27(35):5944–51.
    • (2009) J Clin Oncol , vol.27 , Issue.35 , pp. 5944-5951
    • Pages, F.1    Kirilovsky, A.2    Mlecnik, B.3    Asslaber, M.4    Tosolini, M.5    Bindea, G.6
  • 15
    • 33749319703 scopus 로고    scopus 로고
    • Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
    • COI: 1:CAS:528:DC%2BD28XhtVSnsrnK, PID: 17008531
    • Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960–4.
    • (2006) Science , vol.313 , Issue.5795 , pp. 1960-1964
    • Galon, J.1    Costes, A.2    Sanchez-Cabo, F.3    Kirilovsky, A.4    Mlecnik, B.5    Lagorce-Pages, C.6
  • 16
    • 84899529933 scopus 로고    scopus 로고
    • Koelzer VH, Lugli A, Dawson H, Hadrich M, Berger MD, Borner M, et al. CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival. J Transl Med. 2014;12:81,5876-12-81
    • Koelzer VH, Lugli A, Dawson H, Hadrich M, Berger MD, Borner M, et al. CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival. J Transl Med. 2014;12:81,5876-12-81.
  • 17
    • 79952093380 scopus 로고    scopus 로고
    • Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction
    • PID: 21245428
    • Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. 2011;29(6):610–8.
    • (2011) J Clin Oncol , vol.29 , Issue.6 , pp. 610-618
    • Mlecnik, B.1    Tosolini, M.2    Kirilovsky, A.3    Berger, A.4    Bindea, G.5    Meatchi, T.6
  • 18
    • 33750321707 scopus 로고    scopus 로고
    • Interferons, immunity and cancer immunoediting
    • COI: 1:CAS:528:DC%2BD28XhtFWns7fK, PID: 17063185
    • Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol. 2006;6(11):836–48.
    • (2006) Nat Rev Immunol , vol.6 , Issue.11 , pp. 836-848
    • Dunn, G.P.1    Koebel, C.M.2    Schreiber, R.D.3
  • 19
    • 0028038426 scopus 로고
    • MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation
    • COI: 1:CAS:528:DyaK2cXhs1Srtrs%3D, PID: 8293464
    • Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994;76(2):287–99.
    • (1994) Cell , vol.76 , Issue.2 , pp. 287-299
    • Germain, R.N.1
  • 20
    • 35549003579 scopus 로고    scopus 로고
    • Regulation of interferon-gamma during innate and adaptive immune responses
    • COI: 1:CAS:528:DC%2BD1cXhs1ajtbw%3D, PID: 17981204
    • Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007;96:41–101.
    • (2007) Adv Immunol , vol.96 , pp. 41-101
    • Schoenborn, J.R.1    Wilson, C.B.2
  • 21
    • 0026032553 scopus 로고
    • Functional diversity of T lymphocytes due to secretion of different cytokine patterns
    • COI: 1:CAS:528:DyaK3MXhtF2ku78%3D, PID: 1825981
    • Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 1991;5(2):171–7.
    • (1991) FASEB J , vol.5 , Issue.2 , pp. 171-177
    • Street, N.E.1    Mosmann, T.R.2
  • 22
    • 78649917559 scopus 로고    scopus 로고
    • Granzyme B-induced apoptosis in cancer cells and its regulation (review)
    • COI: 1:CAS:528:DC%2BC3cXhs1SmtrjN, PID: 21042704
    • Rousalova I, Krepela E. Granzyme B-induced apoptosis in cancer cells and its regulation (review). Int J Oncol. 2010;37(6):1361–78.
    • (2010) Int J Oncol , vol.37 , Issue.6 , pp. 1361-1378
    • Rousalova, I.1    Krepela, E.2
  • 23
    • 0038195719 scopus 로고    scopus 로고
    • Molecular mechanisms regulating Th1 immune responses
    • COI: 1:CAS:528:DC%2BD3sXjtF2is7k%3D, PID: 12500979
    • Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol. 2003;21:713–58.
    • (2003) Annu Rev Immunol , vol.21 , pp. 713-758
    • Szabo, S.J.1    Sullivan, B.M.2    Peng, S.L.3    Glimcher, L.H.4
  • 24
    • 3042822267 scopus 로고    scopus 로고
    • Cancer and the chemokine network
    • COI: 1:CAS:528:DC%2BD2cXlt1Oktrs%3D, PID: 15229479
    • Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4(7):540–50.
    • (2004) Nat Rev Cancer , vol.4 , Issue.7 , pp. 540-550
    • Balkwill, F.1
  • 25
    • 77949780426 scopus 로고    scopus 로고
    • Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer
    • COI: 1:CAS:528:DC%2BC3cXlt1Sis7s%3D, PID: 19909745
    • Mlecnik B, Tosolini M, Charoentong P, Kirilovsky A, Bindea G, Berger A, et al. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology. 2010;138(4):1429–40.
    • (2010) Gastroenterology , vol.138 , Issue.4 , pp. 1429-1440
    • Mlecnik, B.1    Tosolini, M.2    Charoentong, P.3    Kirilovsky, A.4    Bindea, G.5    Berger, A.6
  • 26
    • 0031963014 scopus 로고    scopus 로고
    • Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
    • COI: 1:CAS:528:DyaK1cXjtV2msQ%3D%3D, PID: 9419219
    • Bonecchi R, Bianchi G, Bordignon PP, D’Ambrosio D, Lang R, Borsatti A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998;187(1):129–34.
    • (1998) J Exp Med , vol.187 , Issue.1 , pp. 129-134
    • Bonecchi, R.1    Bianchi, G.2    Bordignon, P.P.3    D’Ambrosio, D.4    Lang, R.5    Borsatti, A.6
  • 27
    • 0032536869 scopus 로고    scopus 로고
    • Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
    • COI: 1:CAS:528:DyaK1cXhvFWitr4%3D, PID: 9500790
    • Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998;187(6):875–83.
    • (1998) J Exp Med , vol.187 , Issue.6 , pp. 875-883
    • Sallusto, F.1    Lenig, D.2    Mackay, C.R.3    Lanzavecchia, A.4
  • 28
    • 0032526864 scopus 로고    scopus 로고
    • Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
    • COI: 1:CAS:528:DyaK1cXktVeitr8%3D, PID: 9625760
    • Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med. 1998;187(12):2009–21.
    • (1998) J Exp Med , vol.187 , Issue.12 , pp. 2009-2021
    • Cole, K.E.1    Strick, C.A.2    Paradis, T.J.3    Ogborne, K.T.4    Loetscher, M.5    Gladue, R.P.6
  • 29
    • 79951944636 scopus 로고    scopus 로고
    • CXCR3 ligands: redundant, collaborative and antagonistic functions
    • COI: 1:CAS:528:DC%2BC3MXitVCls7s%3D, PID: 21221121
    • Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol. 2011;89(2):207–15.
    • (2011) Immunol Cell Biol , vol.89 , Issue.2 , pp. 207-215
    • Groom, J.R.1    Luster, A.D.2
  • 30
    • 23944469303 scopus 로고    scopus 로고
    • Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma
    • COI: 1:CAS:528:DC%2BD2MXpsVegtLk%3D, PID: 15856455
    • Musha H, Ohtani H, Mizoi T, Kinouchi M, Nakayama T, Shiiba K, et al. Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma. Int J Cancer. 2005;116(6):949–56.
    • (2005) Int J Cancer , vol.116 , Issue.6 , pp. 949-956
    • Musha, H.1    Ohtani, H.2    Mizoi, T.3    Kinouchi, M.4    Nakayama, T.5    Shiiba, K.6
  • 31
    • 77953290424 scopus 로고    scopus 로고
    • Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration
    • Zimmermann T, Moehler M, Gockel I, Sgourakis GG, Biesterfeld S, Muller M, et al. Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration. Int J Color Dis. 2010;25(4):417–24.
    • (2010) Int J Color Dis , vol.25 , Issue.4 , pp. 417-424
    • Zimmermann, T.1    Moehler, M.2    Gockel, I.3    Sgourakis, G.G.4    Biesterfeld, S.5    Muller, M.6
  • 32
    • 79959714869 scopus 로고    scopus 로고
    • Expression of chemokine receptor CCR5 correlates with the presence of hepatic molecular metastases in K-ras positive human colorectal cancer
    • COI: 1:CAS:528:DC%2BC3MXntlWqu78%3D, PID: 21468700
    • Schimanski CC, Moehler M, Gockel I, Zimmermann T, Lang H, Galle PR, et al. Expression of chemokine receptor CCR5 correlates with the presence of hepatic molecular metastases in K-ras positive human colorectal cancer. J Cancer Res Clin Oncol. 2011;137(7):1139–45.
    • (2011) J Cancer Res Clin Oncol , vol.137 , Issue.7 , pp. 1139-1145
    • Schimanski, C.C.1    Moehler, M.2    Gockel, I.3    Zimmermann, T.4    Lang, H.5    Galle, P.R.6
  • 33
    • 0029986131 scopus 로고    scopus 로고
    • Molecular cloning and functional expression of a new human CC-chemokine receptor gene
    • COI: 1:CAS:528:DyaK28XhtlWit7k%3D, PID: 8639485
    • Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry. 1996;35(11):3362–7.
    • (1996) Biochemistry , vol.35 , Issue.11 , pp. 3362-3367
    • Samson, M.1    Labbe, O.2    Mollereau, C.3    Vassart, G.4    Parmentier, M.5
  • 34
    • 1342329581 scopus 로고    scopus 로고
    • Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation
    • COI: 1:CAS:528:DC%2BD2cXhvVOjs7o%3D, PID: 14975243
    • Catalfamo M, Karpova T, McNally J, Costes SV, Lockett SJ, Bos E, et al. Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity. 2004;20(2):219–30.
    • (2004) Immunity , vol.20 , Issue.2 , pp. 219-230
    • Catalfamo, M.1    Karpova, T.2    McNally, J.3    Costes, S.V.4    Lockett, S.J.5    Bos, E.6
  • 35
    • 0025038599 scopus 로고
    • Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
    • COI: 1:CAS:528:DyaK3cXmtV2ru7g%3D, PID: 1699135
    • Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 1990;347(6294):669–71.
    • (1990) Nature , vol.347 , Issue.6294 , pp. 669-671
    • Schall, T.J.1    Bacon, K.2    Toy, K.J.3    Goeddel, D.V.4
  • 36
    • 84923311842 scopus 로고    scopus 로고
    • Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration
    • PID: 25671296
    • Zumwalt TJ, Arnold M, Goel A, Boland CR. Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration. Oncotarget. 2015;6(5):2981–91.
    • (2015) Oncotarget , vol.6 , Issue.5 , pp. 2981-2991
    • Zumwalt, T.J.1    Arnold, M.2    Goel, A.3    Boland, C.R.4
  • 37
    • 13144249230 scopus 로고    scopus 로고
    • Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells
    • COI: 1:CAS:528:DyaK1cXjtFWku78%3D, PID: 9576945
    • Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Sato H, et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci U S A. 1998;95(10):5690–3.
    • (1998) Proc Natl Acad Sci U S A , vol.95 , Issue.10 , pp. 5690-5693
    • Kawano, T.1    Cui, J.2    Koezuka, Y.3    Toura, I.4    Kaneko, Y.5    Sato, H.6
  • 38
    • 0029874672 scopus 로고    scopus 로고
    • Receptors for HLA class-I molecules in human natural killer cells
    • COI: 1:CAS:528:DyaK28XitlCgtbY%3D, PID: 8717527
    • Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, et al. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol. 1996;14:619–48.
    • (1996) Annu Rev Immunol , vol.14 , pp. 619-648
    • Moretta, A.1    Bottino, C.2    Vitale, M.3    Pende, D.4    Biassoni, R.5    Mingari, M.C.6
  • 39
    • 84867529636 scopus 로고    scopus 로고
    • Sconocchia G, Arriga R, Tornillo L, Terracciano L, Ferrone S, Spagnoli GC. Melanoma cells inhibit NK cell functions. Cancer Res. 2012;72(20):5428,9; author reply 5430
    • Sconocchia G, Arriga R, Tornillo L, Terracciano L, Ferrone S, Spagnoli GC. Melanoma cells inhibit NK cell functions. Cancer Res. 2012;72(20):5428,9; author reply 5430.
  • 40
    • 80054887628 scopus 로고    scopus 로고
    • Benevolo M, Mottolese M, Tremante E, Rollo F, Diodoro MG, Ercolani C, et al. High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis. J Transl Med. 2011;9:184,5876-9-184
    • Benevolo M, Mottolese M, Tremante E, Rollo F, Diodoro MG, Ercolani C, et al. High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis. J Transl Med. 2011;9:184,5876-9-184.
  • 41
    • 84899091942 scopus 로고    scopus 로고
    • Pugh SA, Harrison RJ, Primrose JN, Khakoo SI. T cells but not NK cells are associated with a favourable outcome for resected colorectal liver metastases. BMC Cancer. 2014;14:180,2407-14-180
    • Pugh SA, Harrison RJ, Primrose JN, Khakoo SI. T cells but not NK cells are associated with a favourable outcome for resected colorectal liver metastases. BMC Cancer. 2014;14:180,2407-14-180.
  • 43
    • 79951824956 scopus 로고    scopus 로고
    • Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines
    • COI: 1:CAS:528:DC%2BC3MXitVSqtbo%3D, PID: 21325295
    • Halama N, Braun M, Kahlert C, Spille A, Quack C, Rahbari N, et al. Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines. Clin Cancer Res. 2011;17(4):678–89.
    • (2011) Clin Cancer Res , vol.17 , Issue.4 , pp. 678-689
    • Halama, N.1    Braun, M.2    Kahlert, C.3    Spille, A.4    Quack, C.5    Rahbari, N.6
  • 44
    • 79952282602 scopus 로고    scopus 로고
    • Tumor infiltration by FcgammaRIII (CD16) + myeloid cells is associated with improved survival in patients with colorectal carcinoma
    • COI: 1:CAS:528:DC%2BC3MXktVSgt7Y%3D, PID: 20715106
    • Sconocchia G, Zlobec I, Lugli A, Calabrese D, Iezzi G, Karamitopoulou E, et al. Tumor infiltration by FcgammaRIII (CD16) + myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer. 2011;128(11):2663–72.
    • (2011) Int J Cancer , vol.128 , Issue.11 , pp. 2663-2672
    • Sconocchia, G.1    Zlobec, I.2    Lugli, A.3    Calabrese, D.4    Iezzi, G.5    Karamitopoulou, E.6
  • 45
    • 78349277576 scopus 로고    scopus 로고
    • Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
    • PID: 20927778
    • Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, et al. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol. 2010;222(4):350–66.
    • (2010) J Pathol , vol.222 , Issue.4 , pp. 350-366
    • Nosho, K.1    Baba, Y.2    Tanaka, N.3    Shima, K.4    Hayashi, M.5    Meyerhardt, J.A.6
  • 46
    • 77953976583 scopus 로고    scopus 로고
    • Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer
    • COI: 1:CAS:528:DC%2BC3cXhtVWmtLnN, PID: 20581241
    • Simpson JA, Al-Attar A, Watson NF, Scholefield JH, Ilyas M, Durrant LG. Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer. Gut. 2010;59(7):926–33.
    • (2010) Gut , vol.59 , Issue.7 , pp. 926-933
    • Simpson, J.A.1    Al-Attar, A.2    Watson, N.F.3    Scholefield, J.H.4    Ilyas, M.5    Durrant, L.G.6
  • 47
    • 5544242524 scopus 로고    scopus 로고
    • Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis
    • COI: 1:STN:280:DC%2BD3Mzpt1arsQ%3D%3D, PID: 11438476
    • Guidoboni M, Gafa R, Viel A, Doglioni C, Russo A, Santini A, et al. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol. 2001;159(1):297–304.
    • (2001) Am J Pathol , vol.159 , Issue.1 , pp. 297-304
    • Guidoboni, M.1    Gafa, R.2    Viel, A.3    Doglioni, C.4    Russo, A.5    Santini, A.6
  • 48
    • 70349423483 scopus 로고    scopus 로고
    • Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma
    • COI: 1:CAS:528:DC%2BD1MXht12gtr%2FP, PID: 19577568
    • Sinicrope FA, Rego RL, Ansell SM, Knutson KL, Foster NR, Sargent DJ. Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterology. 2009;137(4):1270–9.
    • (2009) Gastroenterology , vol.137 , Issue.4 , pp. 1270-1279
    • Sinicrope, F.A.1    Rego, R.L.2    Ansell, S.M.3    Knutson, K.L.4    Foster, N.R.5    Sargent, D.J.6
  • 49
    • 0030787373 scopus 로고    scopus 로고
    • Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
    • COI: 1:STN:280:DyaK1c%2FgvF2nug%3D%3D, PID: 9349235
    • Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol. 1997;182(3):318–24.
    • (1997) J Pathol , vol.182 , Issue.3 , pp. 318-324
    • Ropponen, K.M.1    Eskelinen, M.J.2    Lipponen, P.K.3    Alhava, E.4    Kosma, V.M.5
  • 50
    • 84859993702 scopus 로고    scopus 로고
    • Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer
    • PID: 22508783
    • Huh JW, Lee JH, Kim HR. Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer. Arch Surg. 2012;147(4):366–72.
    • (2012) Arch Surg , vol.147 , Issue.4 , pp. 366-372
    • Huh, J.W.1    Lee, J.H.2    Kim, H.R.3
  • 51
    • 67449113782 scopus 로고    scopus 로고
    • Combination of microsatellite instability and lymphocytic infiltrate as a prognostic indicator in colon cancer
    • COI: 1:CAS:528:DC%2BD1MXotFKqur4%3D, PID: 19528382
    • Chang EY, Dorsey PB, Frankhouse J, Lee RG, Walts D, Johnson W, et al. Combination of microsatellite instability and lymphocytic infiltrate as a prognostic indicator in colon cancer. Arch Surg. 2009;144(6):511–5.
    • (2009) Arch Surg , vol.144 , Issue.6 , pp. 511-515
    • Chang, E.Y.1    Dorsey, P.B.2    Frankhouse, J.3    Lee, R.G.4    Walts, D.5    Johnson, W.6
  • 52
    • 79955622234 scopus 로고    scopus 로고
    • Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor
    • COI: 1:CAS:528:DC%2BC3MXlsVeqsLg%3D, PID: 21240258
    • Dahlin AM, Henriksson ML, Van Guelpen B, Stenling R, Oberg A, Rutegard J, et al. Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor. Mod Pathol. 2011;24(5):671–82.
    • (2011) Mod Pathol , vol.24 , Issue.5 , pp. 671-682
    • Dahlin, A.M.1    Henriksson, M.L.2    Van Guelpen, B.3    Stenling, R.4    Oberg, A.5    Rutegard, J.6
  • 53
    • 40949089575 scopus 로고    scopus 로고
    • Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy
    • COI: 1:CAS:528:DC%2BD1cXislSrsL8%3D, PID: 18316563
    • Morris M, Platell C, Iacopetta B. Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy. Clin Cancer Res. 2008;14(5):1413–7.
    • (2008) Clin Cancer Res , vol.14 , Issue.5 , pp. 1413-1417
    • Morris, M.1    Platell, C.2    Iacopetta, B.3
  • 54
    • 78650744474 scopus 로고    scopus 로고
    • TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer
    • PID: 21179245
    • Zlobec I, Karamitopoulou E, Terracciano L, Piscuoglio S, Iezzi G, Muraro MG, et al. TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer. PLoS ONE. 2010;5(12):e14282.
    • (2010) PLoS ONE , vol.5 , Issue.12 , pp. 14282
    • Zlobec, I.1    Karamitopoulou, E.2    Terracciano, L.3    Piscuoglio, S.4    Iezzi, G.5    Muraro, M.G.6
  • 55
    • 84898714462 scopus 로고    scopus 로고
    • +lymphocytes more accurately predicts recurrence and survival than TNM staging for rectal cancer patients
    • +lymphocytes more accurately predicts recurrence and survival than TNM staging for rectal cancer patients.
  • 56
    • 2342514891 scopus 로고    scopus 로고
    • Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis
    • COI: 1:CAS:528:DC%2BD2cXmtF2itrc%3D, PID: 14968119
    • Menon AG, Janssen-van Rhijn CM, Morreau H, Putter H, Tollenaar RA, van de Velde CJ, et al. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab Invest. 2004;84(4):493–501.
    • (2004) Lab Invest , vol.84 , Issue.4 , pp. 493-501
    • Menon, A.G.1    Janssen-van Rhijn, C.M.2    Morreau, H.3    Putter, H.4    Tollenaar, R.A.5    van de Velde, C.J.6
  • 57
    • 77950468866 scopus 로고    scopus 로고
    • Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer
    • COI: 1:CAS:528:DC%2BC3cXis1yhtro%3D, PID: 19908042
    • Suzuki H, Chikazawa N, Tasaka T, Wada J, Yamasaki A, Kitaura Y, et al. Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer. Cancer Immunol Immunother. 2010;59(5):653–61.
    • (2010) Cancer Immunol Immunother , vol.59 , Issue.5 , pp. 653-661
    • Suzuki, H.1    Chikazawa, N.2    Tasaka, T.3    Wada, J.4    Yamasaki, A.5    Kitaura, Y.6
  • 58
    • 84879187714 scopus 로고    scopus 로고
    • Tumor infiltration by chemokine receptor 7 (CCR7)(+) T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer
    • PID: 22754775
    • Correale P, Rotundo MS, Botta C, Del Vecchio MT, Tassone P, Tagliaferri P. Tumor infiltration by chemokine receptor 7 (CCR7)(+) T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer. Oncoimmunology. 2012;1(4):531–2.
    • (2012) Oncoimmunology , vol.1 , Issue.4 , pp. 531-532
    • Correale, P.1    Rotundo, M.S.2    Botta, C.3    Del Vecchio, M.T.4    Tassone, P.5    Tagliaferri, P.6
  • 59
    • 79952281183 scopus 로고    scopus 로고
    • Tumor immunosurveillance in human cancers
    • COI: 1:CAS:528:DC%2BC3MXitlKltLw%3D, PID: 21249426
    • Mlecnik B, Bindea G, Pages F, Galon J. Tumor immunosurveillance in human cancers. Cancer Metastasis Rev. 2011;30(1):5–12.
    • (2011) Cancer Metastasis Rev , vol.30 , Issue.1 , pp. 5-12
    • Mlecnik, B.1    Bindea, G.2    Pages, F.3    Galon, J.4
  • 60
    • 70349968210 scopus 로고    scopus 로고
    • CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer
    • COI: 1:CAS:528:DC%2BD1MXht1GntbjF, PID: 19755986
    • Lugli A, Karamitopoulou E, Panayiotides I, Karakitsos P, Rallis G, Peros G, et al. CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer. Br J Cancer. 2009;101(8):1382–92.
    • (2009) Br J Cancer , vol.101 , Issue.8 , pp. 1382-1392
    • Lugli, A.1    Karamitopoulou, E.2    Panayiotides, I.3    Karakitsos, P.4    Rallis, G.5    Peros, G.6
  • 61
    • 0032529466 scopus 로고    scopus 로고
    • CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer
    • COI: 1:CAS:528:DyaK1cXlsFajsb4%3D, PID: 9721846
    • Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998;58(16):3491–4.
    • (1998) Cancer Res , vol.58 , Issue.16 , pp. 3491-3494
    • Naito, Y.1    Saito, K.2    Shiiba, K.3    Ohuchi, A.4    Saigenji, K.5    Nagura, H.6
  • 62
    • 84864692605 scopus 로고    scopus 로고
    • Prognostic impact of FoxP3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas
    • COI: 1:CAS:528:DC%2BC38XhtFOlt73E, PID: 22879926
    • Yoon HH, Orrock JM, Foster NR, Sargent DJ, Smyrk TC, Sinicrope FA. Prognostic impact of FoxP3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas. PLoS ONE. 2012;7(8):e42274.
    • (2012) PLoS ONE , vol.7 , Issue.8 , pp. 42274
    • Yoon, H.H.1    Orrock, J.M.2    Foster, N.R.3    Sargent, D.J.4    Smyrk, T.C.5    Sinicrope, F.A.6
  • 63
    • 58249089749 scopus 로고    scopus 로고
    • Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer
    • PID: 19064967
    • Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol. 2009;27(2):186–92.
    • (2009) J Clin Oncol , vol.27 , Issue.2 , pp. 186-192
    • Salama, P.1    Phillips, M.2    Grieu, F.3    Morris, M.4    Zeps, N.5    Joseph, D.6
  • 64
    • 77951217044 scopus 로고    scopus 로고
    • High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients
    • COI: 1:CAS:528:DC%2BC3cXjvFKlsLk%3D, PID: 19856313
    • Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, Zingg U, et al. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer. 2010;126(11):2635–43.
    • (2010) Int J Cancer , vol.126 , Issue.11 , pp. 2635-2643
    • Frey, D.M.1    Droeser, R.A.2    Viehl, C.T.3    Zlobec, I.4    Lugli, A.5    Zingg, U.6
  • 65
    • 77954959667 scopus 로고    scopus 로고
    • Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy
    • PID: 20386463
    • Correale P, Rotundo MS, Del Vecchio MT, Remondo C, Migali C, Ginanneschi C, et al. Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy. J Immunother. 2010;33(4):435–41.
    • (2010) J Immunother , vol.33 , Issue.4 , pp. 435-441
    • Correale, P.1    Rotundo, M.S.2    Del Vecchio, M.T.3    Remondo, C.4    Migali, C.5    Ginanneschi, C.6
  • 66
    • 84873822300 scopus 로고    scopus 로고
    • Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer
    • COI: 1:CAS:528:DC%2BC3sXis1akt7s%3D, PID: 23382847
    • Kim M, Grimmig T, Grimm M, Lazariotou M, Meier E, Rosenwald A, et al. Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer. PLoS ONE. 2013;8(1):e53630.
    • (2013) PLoS ONE , vol.8 , Issue.1 , pp. 53630
    • Kim, M.1    Grimmig, T.2    Grimm, M.3    Lazariotou, M.4    Meier, E.5    Rosenwald, A.6
  • 67
    • 0037385330 scopus 로고    scopus 로고
    • Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
    • COI: 1:CAS:528:DC%2BD3sXitlyqs74%3D, PID: 12612578
    • Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4(4):330–6.
    • (2003) Nat Immunol , vol.4 , Issue.4 , pp. 330-336
    • Fontenot, J.D.1    Gavin, M.A.2    Rudensky, A.Y.3
  • 68
    • 0029150110 scopus 로고
    • Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
    • COI: 1:CAS:528:DyaK2MXntFWnurs%3D, PID: 7636184
    • Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155(3):1151–64.
    • (1995) J Immunol , vol.155 , Issue.3 , pp. 1151-1164
    • Sakaguchi, S.1    Sakaguchi, N.2    Asano, M.3    Itoh, M.4    Toda, M.5
  • 69
    • 0035186416 scopus 로고    scopus 로고
    • Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells
    • COI: 1:CAS:528:DC%2BD3MXpt1eisbo%3D, PID: 11722636
    • Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev. 2001;182:207–14.
    • (2001) Immunol Rev , vol.182 , pp. 207-214
    • Weiner, H.L.1
  • 70
    • 0030704726 scopus 로고    scopus 로고
    • A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
    • COI: 1:CAS:528:DyaK2sXmvVSgtb0%3D, PID: 9338786
    • Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389(6652):737–42.
    • (1997) Nature , vol.389 , Issue.6652 , pp. 737-742
    • Groux, H.1    O’Garra, A.2    Bigler, M.3    Rouleau, M.4    Antonenko, S.5    de Vries, J.E.6
  • 71
    • 0034679560 scopus 로고    scopus 로고
    • Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
    • COI: 1:CAS:528:DC%2BD3cXkvFGiu7c%3D, PID: 10899917
    • Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000;192(2):303–10.
    • (2000) J Exp Med , vol.192 , Issue.2 , pp. 303-310
    • Takahashi, T.1    Tagami, T.2    Yamazaki, S.3    Uede, T.4    Shimizu, J.5    Sakaguchi, N.6
  • 72
    • 0037172969 scopus 로고    scopus 로고
    • CD25+CD4+ T cells contribute to the control of memory CD8+ T cells
    • COI: 1:CAS:528:DC%2BD38XltF2ht7o%3D, PID: 12084927
    • Murakami M, Sakamoto A, Bender J, Kappler J, Marrack P. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc Natl Acad Sci U S A. 2002;99(13):8832–7.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , Issue.13 , pp. 8832-8837
    • Murakami, M.1    Sakamoto, A.2    Bender, J.3    Kappler, J.4    Marrack, P.5
  • 73
    • 54949139152 scopus 로고    scopus 로고
    • CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer
    • PID: 17205133
    • Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, Harrop R, et al. CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS ONE. 2006;1:e129.
    • (2006) PLoS ONE , vol.1 , pp. 129
    • Clarke, S.L.1    Betts, G.J.2    Plant, A.3    Wright, K.L.4    El-Shanawany, T.M.5    Harrop, R.6
  • 74
    • 0036858838 scopus 로고    scopus 로고
    • Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens
    • COI: 1:CAS:528:DC%2BD38XovF2qs7c%3D, PID: 12555672
    • Golgher D, Jones E, Powrie F, Elliott T, Gallimore A. Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur J Immunol. 2002;32(11):3267–75.
    • (2002) Eur J Immunol , vol.32 , Issue.11 , pp. 3267-3275
    • Golgher, D.1    Jones, E.2    Powrie, F.3    Elliott, T.4    Gallimore, A.5
  • 75
    • 84861783871 scopus 로고    scopus 로고
    • The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature
    • de Leeuw RJ, Kost SE, Kakal JA, Nelson BH. The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clin Cancer Res. 2012;18(11):3022–9.
    • (2012) Clin Cancer Res , vol.18 , Issue.11 , pp. 3022-3029
    • de Leeuw, R.J.1    Kost, S.E.2    Kakal, J.A.3    Nelson, B.H.4
  • 78
    • 79959742164 scopus 로고    scopus 로고
    • Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
    • COI: 1:CAS:528:DC%2BC3MXnslOrsL4%3D, PID: 21644034
    • Ladoire S, Martin F, Ghiringhelli F. Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother. 2011;60(7):909–18.
    • (2011) Cancer Immunol Immunother , vol.60 , Issue.7 , pp. 909-918
    • Ladoire, S.1    Martin, F.2    Ghiringhelli, F.3
  • 79
    • 83455203338 scopus 로고    scopus 로고
    • Heusinkveld M, van der Burg SH. Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med. 2011;9:216,5876-9-216
    • Heusinkveld M, van der Burg SH. Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med. 2011;9:216,5876-9-216.
  • 80
    • 84855219213 scopus 로고    scopus 로고
    • Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response
    • COI: 1:CAS:528:DC%2BC3MXhsF2qsbzM, PID: 22009685
    • Ong SM, Tan YC, Beretta O, Jiang D, Yeap WH, Tai JJ, et al. Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response. Eur J Immunol. 2012;42(1):89–100.
    • (2012) Eur J Immunol , vol.42 , Issue.1 , pp. 89-100
    • Ong, S.M.1    Tan, Y.C.2    Beretta, O.3    Jiang, D.4    Yeap, W.H.5    Tai, J.J.6
  • 81
    • 80055014005 scopus 로고    scopus 로고
    • Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer
    • PID: 21598004
    • Bauer K, Michel S, Reuschenbach M, Nelius N, von Knebel Doeberitz M, Kloor M. Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer. Fam Cancer. 2011;10(3):557–65.
    • (2011) Fam Cancer , vol.10 , Issue.3 , pp. 557-565
    • Bauer, K.1    Michel, S.2    Reuschenbach, M.3    Nelius, N.4    von Knebel Doeberitz, M.5    Kloor, M.6
  • 82
    • 0036895601 scopus 로고    scopus 로고
    • Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process
    • COI: 1:CAS:528:DC%2BD38XpsVahtr8%3D, PID: 12460925
    • Barbera-Guillem E, Nyhus JK, Wolford CC, Friece CR, Sampsel JW. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res. 2002;62(23):7042–9.
    • (2002) Cancer Res , vol.62 , Issue.23 , pp. 7042-7049
    • Barbera-Guillem, E.1    Nyhus, J.K.2    Wolford, C.C.3    Friece, C.R.4    Sampsel, J.W.5
  • 83
    • 80053159303 scopus 로고    scopus 로고
    • The parallel lives of angiogenesis and immunosuppression: cancer and other tales
    • COI: 1:CAS:528:DC%2BC3MXht1ajur7E, PID: 21941296
    • Motz GT, Coukos G. The parallel lives of angiogenesis and immunosuppression: cancer and other tales. Nat Rev Immunol. 2011;11(10):702–11.
    • (2011) Nat Rev Immunol , vol.11 , Issue.10 , pp. 702-711
    • Motz, G.T.1    Coukos, G.2
  • 84
    • 84874236258 scopus 로고    scopus 로고
    • Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma
    • COI: 1:CAS:528:DC%2BC3sXjsF2iu7g%3D, PID: 23437326
    • Zhang B, Wang Z, Wu L, Zhang M, Li W, Ding J, et al. Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma. PLoS ONE. 2013;8(2):e57114.
    • (2013) PLoS ONE , vol.8 , Issue.2 , pp. 57114
    • Zhang, B.1    Wang, Z.2    Wu, L.3    Zhang, M.4    Li, W.5    Ding, J.6
  • 85
    • 84863923651 scopus 로고    scopus 로고
    • Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma
    • PID: 22783056
    • Sun HL, Zhou X, Xue YF, Wang K, Shen YF, Mao JJ, et al. Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma. World J Gastroenterol. 2012;18(25):3303–9.
    • (2012) World J Gastroenterol , vol.18 , Issue.25 , pp. 3303-3309
    • Sun, H.L.1    Zhou, X.2    Xue, Y.F.3    Wang, K.4    Shen, Y.F.5    Mao, J.J.6
  • 86
    • 5444225991 scopus 로고    scopus 로고
    • Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
    • COI: 1:CAS:528:DC%2BD2cXpsF2rtLo%3D, PID: 15488763
    • Yang L, DeBusk LM, Fukuda K, Fingleton B, Green-Jarvis B, Shyr Y, et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell. 2004;6(4):409–21.
    • (2004) Cancer Cell , vol.6 , Issue.4 , pp. 409-421
    • Yang, L.1    DeBusk, L.M.2    Fukuda, K.3    Fingleton, B.4    Green-Jarvis, B.5    Shyr, Y.6
  • 87
    • 1642536454 scopus 로고    scopus 로고
    • Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species
    • COI: 1:CAS:528:DC%2BD2cXnvVGl, PID: 14707072
    • Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol. 2004;172(2):989–99.
    • (2004) J Immunol , vol.172 , Issue.2 , pp. 989-999
    • Kusmartsev, S.1    Nefedova, Y.2    Yoder, D.3    Gabrilovich, D.I.4
  • 88
    • 84899753178 scopus 로고    scopus 로고
    • PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
    • COI: 1:CAS:528:DC%2BC2cXotVCjs7w%3D, PID: 24778419
    • Noman MZ, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, et al. PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med. 2014;211(5):781–90.
    • (2014) J Exp Med , vol.211 , Issue.5 , pp. 781-790
    • Noman, M.Z.1    Desantis, G.2    Janji, B.3    Hasmim, M.4    Karray, S.5    Dessen, P.6
  • 89
    • 33947432482 scopus 로고    scopus 로고
    • High macrophage infiltration along the tumor front correlates with improved survival in colon cancer
    • COI: 1:CAS:528:DC%2BD2sXitlSjt70%3D, PID: 17332291
    • Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res. 2007;13(5):1472–9.
    • (2007) Clin Cancer Res , vol.13 , Issue.5 , pp. 1472-1479
    • Forssell, J.1    Oberg, A.2    Henriksson, M.L.3    Stenling, R.4    Jung, A.5    Palmqvist, R.6
  • 90
    • 80355147292 scopus 로고    scopus 로고
    • Type I interferon is selectively required by dendritic cells for immune rejection of tumors
    • COI: 1:CAS:528:DC%2BC3MXht1KjsbnL, PID: 21930769
    • Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault JM, et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med. 2011;208(10):1989–2003.
    • (2011) J Exp Med , vol.208 , Issue.10 , pp. 1989-2003
    • Diamond, M.S.1    Kinder, M.2    Matsushita, H.3    Mashayekhi, M.4    Dunn, G.P.5    Archambault, J.M.6
  • 91
    • 0015619335 scopus 로고
    • Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution
    • COI: 1:STN:280:DyaE3s7ntFejsw%3D%3D, PID: 4573839
    • Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med. 1973;137(5):1142–62.
    • (1973) J Exp Med , vol.137 , Issue.5 , pp. 1142-1162
    • Steinman, R.M.1    Cohn, Z.A.2
  • 92
    • 35748978808 scopus 로고    scopus 로고
    • Taming cancer by inducing immunity via dendritic cells
    • COI: 1:CAS:528:DC%2BD2sXhsVKgtrrK, PID: 17979844
    • Palucka AK, Ueno H, Fay JW, Banchereau J. Taming cancer by inducing immunity via dendritic cells. Immunol Rev. 2007;220:129–50.
    • (2007) Immunol Rev , vol.220 , pp. 129-150
    • Palucka, A.K.1    Ueno, H.2    Fay, J.W.3    Banchereau, J.4
  • 93
    • 84863116620 scopus 로고    scopus 로고
    • Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells
    • COI: 1:CAS:528:DC%2BC38XhtFSqu78%3D, PID: 22213806
    • Li D, Romain G, Flamar AL, Duluc D, Dullaers M, Li XH, et al. Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells. J Exp Med. 2012;209(1):109–21.
    • (2012) J Exp Med , vol.209 , Issue.1 , pp. 109-121
    • Li, D.1    Romain, G.2    Flamar, A.L.3    Duluc, D.4    Dullaers, M.5    Li, X.H.6
  • 94
    • 33748269365 scopus 로고    scopus 로고
    • Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment II
    • COI: 1:STN:280:DC%2BD28rlsVSktQ%3D%3D, PID: 16978205
    • Taylor CR, Levenson RM. Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment II. Histopathology. 2006;49(4):411–24.
    • (2006) Histopathology , vol.49 , Issue.4 , pp. 411-424
    • Taylor, C.R.1    Levenson, R.M.2
  • 95
    • 0035124087 scopus 로고    scopus 로고
    • Dendritic cell infiltration in colon cancer
    • COI: 1:STN:280:DC%2BD3M7msVGqtw%3D%3D
    • Schwaab T, Weiss JE, Schned AR, Barth Jr RJ. Dendritic cell infiltration in colon cancer. J Immunother. 2001;24(2):130–7.
    • (2001) J Immunother , vol.24 , Issue.2 , pp. 130-137
    • Schwaab, T.1    Weiss, J.E.2    Schned, A.R.3    Barth, R.J.4
  • 96
    • 5644255722 scopus 로고    scopus 로고
    • Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells
    • COI: 1:CAS:528:DC%2BD2cXns12nsLg%3D, PID: 15197496
    • Dadabayev AR, Sandel MH, Menon AG, Morreau H, Melief CJ, Offringa R, et al. Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells. Cancer Immunol Immunother. 2004;53(11):978–86.
    • (2004) Cancer Immunol Immunother , vol.53 , Issue.11 , pp. 978-986
    • Dadabayev, A.R.1    Sandel, M.H.2    Menon, A.G.3    Morreau, H.4    Melief, C.J.5    Offringa, R.6
  • 97
    • 49649083838 scopus 로고    scopus 로고
    • Dendritic cell infiltration pattern along the colorectal adenoma-carcinoma sequence
    • COI: 1:CAS:528:DC%2BD1cXpslKisLg%3D, PID: 18754318
    • Yuan A, Steigen SE, Goll R, Vonen B, Husbekk A, Cui G, et al. Dendritic cell infiltration pattern along the colorectal adenoma-carcinoma sequence. APMIS. 2008;116(6):445–56.
    • (2008) APMIS , vol.116 , Issue.6 , pp. 445-456
    • Yuan, A.1    Steigen, S.E.2    Goll, R.3    Vonen, B.4    Husbekk, A.5    Cui, G.6
  • 98
    • 84910015637 scopus 로고    scopus 로고
    • PD-1(+) CD8(+) T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients
    • COI: 1:CAS:528:DC%2BC2cXhtlahsbrM, PID: 25093496
    • Wu X, Zhang H, Xing Q, Cui J, Li J, Li Y, et al. PD-1(+) CD8(+) T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients. Br J Cancer. 2014;111(7):1391–9.
    • (2014) Br J Cancer , vol.111 , Issue.7 , pp. 1391-1399
    • Wu, X.1    Zhang, H.2    Xing, Q.3    Cui, J.4    Li, J.5    Li, Y.6
  • 99
    • 84895168217 scopus 로고    scopus 로고
    • Highly prevalent colorectal cancer-infiltrating LAP(+) Foxp3(−) T cells exhibit more potent immunosuppressive activity than Foxp3(+) regulatory T cells
    • COI: 1:CAS:528:DC%2BC3sXhsFSls7vE, PID: 24064667, By screening for intra-tumoral regulatory T cells, the authors identified these cells to express CTLA-4 and LAG-3 and secrete TFG-β and IL-10
    • Scurr M, Ladell K, Besneux M, Christian A, Hockey T, Smart K, et al. Highly prevalent colorectal cancer-infiltrating LAP(+) Foxp3(−) T cells exhibit more potent immunosuppressive activity than Foxp3(+) regulatory T cells. Mucosal Immunol. 2014;7(2):428–39. By screening for intra-tumoral regulatory T cells, the authors identified these cells to express CTLA-4 and LAG-3 and secrete TFG-β and IL-10.
    • (2014) Mucosal Immunol , vol.7 , Issue.2 , pp. 428-439
    • Scurr, M.1    Ladell, K.2    Besneux, M.3    Christian, A.4    Hockey, T.5    Smart, K.6
  • 100
    • 0035082154 scopus 로고    scopus 로고
    • T cell proliferation is blocked by indoleamine 2,3-dioxygenase
    • COI: 1:CAS:528:DC%2BD3MXitV2hsbs%3D, PID: 11266894
    • Frumento G, Rotondo R, Tonetti M, Ferrara GB. T cell proliferation is blocked by indoleamine 2,3-dioxygenase. Transplant Proc. 2001;33(1–2):428–30.
    • (2001) Transplant Proc , vol.33 , Issue.1-2 , pp. 428-430
    • Frumento, G.1    Rotondo, R.2    Tonetti, M.3    Ferrara, G.B.4
  • 101
    • 77954801079 scopus 로고    scopus 로고
    • Improved survival with ipilimumab in patients with metastatic melanoma
    • COI: 1:CAS:528:DC%2BC3cXhtVCrtrbN, PID: 20525992
    • Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711–23.
    • (2010) N Engl J Med , vol.363 , Issue.8 , pp. 711-723
    • Hodi, F.S.1    O’Day, S.J.2    McDermott, D.F.3    Weber, R.W.4    Sosman, J.A.5    Haanen, J.B.6
  • 102
    • 33847407907 scopus 로고    scopus 로고
    • A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy
    • PID: 17289891
    • O’Mahony D, Morris JC, Quinn C, Gao W, Wilson WH, Gause B, et al. A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy. Clin Cancer Res. 2007;13(3):958–64.
    • (2007) Clin Cancer Res , vol.13 , Issue.3 , pp. 958-964
    • O’Mahony, D.1    Morris, J.C.2    Quinn, C.3    Gao, W.4    Wilson, W.H.5    Gause, B.6
  • 103
    • 77955292303 scopus 로고    scopus 로고
    • Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer
    • COI: 1:CAS:528:DC%2BC3cXhtVGis7fE, PID: 20498386
    • Chung KY, Gore I, Fong L, Venook A, Beck SB, Dorazio P, et al. Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer. J Clin Oncol. 2010;28(21):3485–90.
    • (2010) J Clin Oncol , vol.28 , Issue.21 , pp. 3485-3490
    • Chung, K.Y.1    Gore, I.2    Fong, L.3    Venook, A.4    Beck, S.B.5    Dorazio, P.6
  • 104
    • 77954899030 scopus 로고    scopus 로고
    • Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates
    • COI: 1:CAS:528:DC%2BC3cXpslajtLw%3D, PID: 20516446
    • Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol. 2010;28(19):3167–75.
    • (2010) J Clin Oncol , vol.28 , Issue.19 , pp. 3167-3175
    • Brahmer, J.R.1    Drake, C.G.2    Wollner, I.3    Powderly, J.D.4    Picus, J.5    Sharfman, W.H.6
  • 105
    • 84862859820 scopus 로고    scopus 로고
    • Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
    • COI: 1:CAS:528:DC%2BC38XhtV2rs7fN, PID: 22658127
    • Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366(26):2443–54.
    • (2012) N Engl J Med , vol.366 , Issue.26 , pp. 2443-2454
    • Topalian, S.L.1    Hodi, F.S.2    Brahmer, J.R.3    Gettinger, S.N.4    Smith, D.C.5    McDermott, D.F.6
  • 106
    • 84862903106 scopus 로고    scopus 로고
    • Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
    • COI: 1:CAS:528:DC%2BC38XhtV2rsbnJ, PID: 22658128
    • Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366(26):2455–65.
    • (2012) N Engl J Med , vol.366 , Issue.26 , pp. 2455-2465
    • Brahmer, J.R.1    Tykodi, S.S.2    Chow, L.Q.3    Hwu, W.J.4    Topalian, S.L.5    Hwu, P.6
  • 107
    • 85018112280 scopus 로고    scopus 로고
    • H1/CTL activities are countered by immunosuppressive barriers
    • H1/CTL activities are countered by immunosuppressive barriers.
  • 108
    • 84904272238 scopus 로고    scopus 로고
    • The effect of immune microenvironment on the progression and prognosis of colorectal cancer. Med Oncol. 2014;31(8):82,014-0082-9
    • Chen J, Chen Z. The effect of immune microenvironment on the progression and prognosis of colorectal cancer. Med Oncol. 2014;31(8):82,014-0082-9. Epub 2014 Jul 18.
    • (2014) Epub , pp. 18
    • Chen, J.1    Chen, Z.2
  • 109
    • 0032711858 scopus 로고    scopus 로고
    • Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses
    • COI: 1:CAS:528:DyaK1MXotVehsrw%3D, PID: 10601994
    • Prigent P, El Mir S, Dreano M, Triebel F. Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses. Eur J Immunol. 1999;29(12):3867–76.
    • (1999) Eur J Immunol , vol.29 , Issue.12 , pp. 3867-3876
    • Prigent, P.1    El Mir, S.2    Dreano, M.3    Triebel, F.4
  • 110
    • 33644775726 scopus 로고    scopus 로고
    • Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells
    • COI: 1:CAS:528:DC%2BD28XhsFalt7g%3D, PID: 16489067
    • Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res. 2006;12(4):1144–51.
    • (2006) Clin Cancer Res , vol.12 , Issue.4 , pp. 1144-1151
    • Brandacher, G.1    Perathoner, A.2    Ladurner, R.3    Schneeberger, S.4    Obrist, P.5    Winkler, C.6
  • 111
    • 0027314321 scopus 로고
    • The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers
    • COI: 1:CAS:528:DyaK3sXltVyms7c%3D, PID: 8507544
    • Satoh K, Kan N, Okino T, Mise K, Yamasaki S, Harada T, et al. The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers. Biotherapy. 1993;6(1):41–9.
    • (1993) Biotherapy , vol.6 , Issue.1 , pp. 41-49
    • Satoh, K.1    Kan, N.2    Okino, T.3    Mise, K.4    Yamasaki, S.5    Harada, T.6
  • 112
    • 3042771504 scopus 로고    scopus 로고
    • Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis
    • PID: 15221919
    • Gardini A, Ercolani G, Riccobon A, Ravaioli M, Ridolfi L, Flamini E, et al. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. J Surg Oncol. 2004;87(1):46–52.
    • (2004) J Surg Oncol , vol.87 , Issue.1 , pp. 46-52
    • Gardini, A.1    Ercolani, G.2    Riccobon, A.3    Ravaioli, M.4    Ridolfi, L.5    Flamini, E.6
  • 113
    • 0032578693 scopus 로고    scopus 로고
    • Expression of signal transducing T-cell receptor zeta molecules after adoptive immunotherapy in patients with gastric and colon cancer
    • COI: 1:CAS:528:DyaK1cXmvVektLs%3D, PID: 9766562
    • Kono K, Ichihara F, Iizuka H, Sekikawa T, Matsumoto Y. Expression of signal transducing T-cell receptor zeta molecules after adoptive immunotherapy in patients with gastric and colon cancer. Int J Cancer. 1998;78(3):301–5.
    • (1998) Int J Cancer , vol.78 , Issue.3 , pp. 301-305
    • Kono, K.1    Ichihara, F.2    Iizuka, H.3    Sekikawa, T.4    Matsumoto, Y.5
  • 114
    • 77954960188 scopus 로고    scopus 로고
    • Pilot study of sentinel-node-based adoptive immunotherapy in advanced colorectal cancer
    • PID: 20119674
    • Karlsson M, Marits P, Dahl K, Dagoo T, Enerback S, Thorn M, et al. Pilot study of sentinel-node-based adoptive immunotherapy in advanced colorectal cancer. Ann Surg Oncol. 2010;17(7):1747–57.
    • (2010) Ann Surg Oncol , vol.17 , Issue.7 , pp. 1747-1757
    • Karlsson, M.1    Marits, P.2    Dahl, K.3    Dagoo, T.4    Enerback, S.5    Thorn, M.6
  • 115
    • 33646851253 scopus 로고    scopus 로고
    • Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer
    • COI: 1:CAS:528:DC%2BD28XksFKnurs%3D, PID: 16641897
    • Marits P, Karlsson M, Dahl K, Larsson P, Wanders A, Thorn M, et al. Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer. Br J Cancer. 2006;94(10):1478–84.
    • (2006) Br J Cancer , vol.94 , Issue.10 , pp. 1478-1484
    • Marits, P.1    Karlsson, M.2    Dahl, K.3    Larsson, P.4    Wanders, A.5    Thorn, M.6
  • 116
    • 0038185191 scopus 로고    scopus 로고
    • T lymphocytes isolated from patients with advanced colorectal cancer are suitable for gene immunotherapy approaches
    • COI: 1:CAS:528:DC%2BD3sXisFahtL4%3D, PID: 12671714
    • Sheen AJ, Sherlock DJ, Irlam J, Hawkins RE, Gilham DE. T lymphocytes isolated from patients with advanced colorectal cancer are suitable for gene immunotherapy approaches. Br J Cancer. 2003;88(7):1119–27.
    • (2003) Br J Cancer , vol.88 , Issue.7 , pp. 1119-1127
    • Sheen, A.J.1    Sherlock, D.J.2    Irlam, J.3    Hawkins, R.E.4    Gilham, D.E.5
  • 117
    • 0034788243 scopus 로고    scopus 로고
    • MHC antigens and tumor escape from immune surveillance
    • COI: 1:CAS:528:DC%2BD38Xitl2jsb4%3D, PID: 11665717
    • Garrido F, Algarra I. MHC antigens and tumor escape from immune surveillance. Adv Cancer Res. 2001;83:117–58.
    • (2001) Adv Cancer Res , vol.83 , pp. 117-158
    • Garrido, F.1    Algarra, I.2
  • 118
    • 77950475517 scopus 로고    scopus 로고
    • Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2
    • COI: 1:CAS:528:DC%2BC3cXitlaitb4%3D, PID: 20179677
    • Morgan RA, Yang JC, Kitano M, Dudley ME, Laurencot CM, Rosenberg SA. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol Ther. 2010;18(4):843–51.
    • (2010) Mol Ther , vol.18 , Issue.4 , pp. 843-851
    • Morgan, R.A.1    Yang, J.C.2    Kitano, M.3    Dudley, M.E.4    Laurencot, C.M.5    Rosenberg, S.A.6
  • 119
    • 79952187823 scopus 로고    scopus 로고
    • T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis
    • COI: 1:CAS:528:DC%2BC3cXhsFGksb3M, PID: 21157437
    • Parkhurst MR, Yang JC, Langan RC, Dudley ME, Nathan DA, Feldman SA, et al. T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther. 2011;19(3):620–6.
    • (2011) Mol Ther , vol.19 , Issue.3 , pp. 620-626
    • Parkhurst, M.R.1    Yang, J.C.2    Langan, R.C.3    Dudley, M.E.4    Nathan, D.A.5    Feldman, S.A.6
  • 120
    • 55949125601 scopus 로고    scopus 로고
    • Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
    • COI: 1:CAS:528:DC%2BD1cXhsVyqsrbO, PID: 18809613
    • Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U, et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol. 2008;26(32):5233–9.
    • (2008) J Clin Oncol , vol.26 , Issue.32 , pp. 5233-5239
    • Dudley, M.E.1    Yang, J.C.2    Sherry, R.3    Hughes, M.S.4    Royal, R.5    Kammula, U.6
  • 121
    • 84878359155 scopus 로고    scopus 로고
    • Ridolfi L, Petrini M, Granato AM, Gentilcore G, Simeone E, Ascierto PA, et al. Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients. J Transl Med. 2013;11:135,5876-11-135
    • Ridolfi L, Petrini M, Granato AM, Gentilcore G, Simeone E, Ascierto PA, et al. Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients. J Transl Med. 2013;11:135,5876-11-135.
  • 122
    • 84929947697 scopus 로고    scopus 로고
    • Scurr M, Bloom A, Pembroke T, Srinivasan R, Brown C, Smart K, et al. Escalating regulation of 5T4-specific IFN-gamma CD4 T cells distinguishes colorectal cancer patients from healthy controls and provides a target for therapy. Cancer Immunol Res. 2013;1(6):10.1158/2326,6066.CIR-13-0035
    • Scurr M, Bloom A, Pembroke T, Srinivasan R, Brown C, Smart K, et al. Escalating regulation of 5T4-specific IFN-gamma CD4 T cells distinguishes colorectal cancer patients from healthy controls and provides a target for therapy. Cancer Immunol Res. 2013;1(6):10.1158/2326,6066.CIR-13-0035.
  • 123
    • 19944380433 scopus 로고    scopus 로고
    • Reduced-intensity allogeneic hematopoietic stem-cell transplantation as an immunotherapy for metastatic colorectal cancer
    • PID: 15614146
    • Kojima R, Kami M, Hori A, Murashige N, Ohnishi M, Kim SW, et al. Reduced-intensity allogeneic hematopoietic stem-cell transplantation as an immunotherapy for metastatic colorectal cancer. Transplantation. 2004;78(12):1740–6.
    • (2004) Transplantation , vol.78 , Issue.12 , pp. 1740-1746
    • Kojima, R.1    Kami, M.2    Hori, A.3    Murashige, N.4    Ohnishi, M.5    Kim, S.W.6
  • 124
    • 43449127777 scopus 로고    scopus 로고
    • Graft-versus-tumor effect after reduced-intensity allogeneic hematopoietic stem cell transplantation in a patient with advanced colon cancer
    • PID: 18463966
    • Hashino S, Kobayashi S, Takahata M, Onozawa M, Nakagawa M, Kawamura T, et al. Graft-versus-tumor effect after reduced-intensity allogeneic hematopoietic stem cell transplantation in a patient with advanced colon cancer. Int J Clin Oncol. 2008;13(2):176–80.
    • (2008) Int J Clin Oncol , vol.13 , Issue.2 , pp. 176-180
    • Hashino, S.1    Kobayashi, S.2    Takahata, M.3    Onozawa, M.4    Nakagawa, M.5    Kawamura, T.6
  • 125
    • 68049102310 scopus 로고    scopus 로고
    • Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia
    • COI: 1:CAS:528:DC%2BD1MXosV2ltbk%3D, PID: 19567591
    • Nishida T, Hudecek M, Kostic A, Bleakley M, Warren EH, Maloney D, et al. Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia. Clin Cancer Res. 2009;15(14):4759–68.
    • (2009) Clin Cancer Res , vol.15 , Issue.14 , pp. 4759-4768
    • Nishida, T.1    Hudecek, M.2    Kostic, A.3    Bleakley, M.4    Warren, E.H.5    Maloney, D.6
  • 126
    • 4544250251 scopus 로고    scopus 로고
    • Indium-111-labelled donor-lymphocyte infusion by way of hepatic artery and radio-frequency ablation against liver metastases of renal and colon carcinoma after allogeneic hematopoietic stem-cell transplantation
    • PID: 15371671
    • Barkholt L, Danielsson R, Calissendorff B, Svensson L, Malihi R, Remberger M, et al. Indium-111-labelled donor-lymphocyte infusion by way of hepatic artery and radio-frequency ablation against liver metastases of renal and colon carcinoma after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2004;78(5):697–703.
    • (2004) Transplantation , vol.78 , Issue.5 , pp. 697-703
    • Barkholt, L.1    Danielsson, R.2    Calissendorff, B.3    Svensson, L.4    Malihi, R.5    Remberger, M.6
  • 127
    • 0036281797 scopus 로고    scopus 로고
    • Acute graft-versus-host disease does not require alloantigen expression on host epithelium
    • COI: 1:CAS:528:DC%2BD38XktVyitrY%3D, PID: 12042807
    • Teshima T, Ordemann R, Reddy P, Gagin S, Liu C, Cooke KR, et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002;8(6):575–81.
    • (2002) Nat Med , vol.8 , Issue.6 , pp. 575-581
    • Teshima, T.1    Ordemann, R.2    Reddy, P.3    Gagin, S.4    Liu, C.5    Cooke, K.R.6
  • 128
    • 0035694925 scopus 로고    scopus 로고
    • A graft-versus-colonic cancer effect of allogeneic stem cell transplantation
    • COI: 1:STN:280:DC%2BD38%2Fns1OjsA%3D%3D, PID: 11803361
    • Zetterquist H, Hentschke P, Thorne A, Wernerson A, Mattsson J, Uzunel M, et al. A graft-versus-colonic cancer effect of allogeneic stem cell transplantation. Bone Marrow Transplant. 2001;28(12):1161–6.
    • (2001) Bone Marrow Transplant , vol.28 , Issue.12 , pp. 1161-1166
    • Zetterquist, H.1    Hentschke, P.2    Thorne, A.3    Wernerson, A.4    Mattsson, J.5    Uzunel, M.6
  • 129
    • 33646435801 scopus 로고    scopus 로고
    • Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD
    • COI: 1:CAS:528:DC%2BD28Xkt1Ghsrg%3D, PID: 16403911
    • Carnevale-Schianca F, Cignetti A, Capaldi A, Vitaggio K, Vallario A, Ricchiardi A, et al. Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD. Blood. 2006;107(9):3795–803.
    • (2006) Blood , vol.107 , Issue.9 , pp. 3795-3803
    • Carnevale-Schianca, F.1    Cignetti, A.2    Capaldi, A.3    Vitaggio, K.4    Vallario, A.5    Ricchiardi, A.6
  • 130
    • 20844445349 scopus 로고    scopus 로고
    • Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma
    • COI: 1:CAS:528:DC%2BD3sXhs1yht7w%3D, PID: 12621459
    • Hentschke P, Barkholt L, Uzunel M, Mattsson J, Wersall P, Pisa P, et al. Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma. Bone Marrow Transplant. 2003;31(4):253–61.
    • (2003) Bone Marrow Transplant , vol.31 , Issue.4 , pp. 253-261
    • Hentschke, P.1    Barkholt, L.2    Uzunel, M.3    Mattsson, J.4    Wersall, P.5    Pisa, P.6
  • 131
    • 59549091676 scopus 로고    scopus 로고
    • Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience
    • COI: 1:CAS:528:DC%2BD1MXjslKqur0%3D, PID: 19203723
    • Aglietta M, Barkholt L, Schianca FC, Caravelli D, Omazic B, Minotto C, et al. Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience. Biol Blood Marrow Transplant. 2009;15(3):326–35.
    • (2009) Biol Blood Marrow Transplant , vol.15 , Issue.3 , pp. 326-335
    • Aglietta, M.1    Barkholt, L.2    Schianca, F.C.3    Caravelli, D.4    Omazic, B.5    Minotto, C.6
  • 132
    • 84908510270 scopus 로고    scopus 로고
    • A paradoxical pattern of indoleamine 2,3-dioxygenase expression in the colon tissues of patients with acute graft-versus-host disease
    • COI: 1:CAS:528:DC%2BC2cXhsFCitbzO, PID: 24732701
    • Park G, Choi YJ, Lee SE, Lim JY, Lee C, Choi EY, et al. A paradoxical pattern of indoleamine 2,3-dioxygenase expression in the colon tissues of patients with acute graft-versus-host disease. Exp Hematol. 2014;42(9):734–40.
    • (2014) Exp Hematol , vol.42 , Issue.9 , pp. 734-740
    • Park, G.1    Choi, Y.J.2    Lee, S.E.3    Lim, J.Y.4    Lee, C.5    Choi, E.Y.6
  • 133
    • 84858780815 scopus 로고    scopus 로고
    • Cancer immunotherapy via dendritic cells
    • COI: 1:CAS:528:DC%2BC38XksVehtrY%3D, PID: 22437871
    • Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer. 2012;12(4):265–77.
    • (2012) Nat Rev Cancer , vol.12 , Issue.4 , pp. 265-277
    • Palucka, K.1    Banchereau, J.2
  • 134
    • 0036716966 scopus 로고    scopus 로고
    • Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients
    • COI: 1:CAS:528:DC%2BD38XnvVWisL0%3D, PID: 12231517
    • Conry RM, Curiel DT, Strong TV, Moore SE, Allen KO, Barlow DL, et al. Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients. Clin Cancer Res. 2002;8(9):2782–7.
    • (2002) Clin Cancer Res , vol.8 , Issue.9 , pp. 2782-2787
    • Conry, R.M.1    Curiel, D.T.2    Strong, T.V.3    Moore, S.E.4    Allen, K.O.5    Barlow, D.L.6
  • 135
    • 0035992254 scopus 로고    scopus 로고
    • Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival
    • COI: 1:CAS:528:DC%2BD38XmtVWit7k%3D, PID: 12114402
    • Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. Clin Cancer Res. 2002;8(7):2044–51.
    • (2002) Clin Cancer Res , vol.8 , Issue.7 , pp. 2044-2051
    • Moulton, H.M.1    Yoshihara, P.H.2    Mason, D.H.3    Iversen, P.L.4    Triozzi, P.L.5
  • 136
    • 84907598532 scopus 로고    scopus 로고
    • A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan
    • COI: 1:CAS:528:DC%2BC2cXhtF2ksrfO, PID: 25030089
    • Rocha-Lima CM, de Queiroz Marques Junior E, Bayraktar S, Broome P, Weissman C, Nowacki M, et al. A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan. Cancer Chemother Pharmacol. 2014;74(3):479–86.
    • (2014) Cancer Chemother Pharmacol , vol.74 , Issue.3 , pp. 479-486
    • Rocha-Lima, C.M.1    de Queiroz Marques Junior, E.2    Bayraktar, S.3    Broome, P.4    Weissman, C.5    Nowacki, M.6
  • 137
    • 84880916286 scopus 로고    scopus 로고
    • Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
    • COI: 1:CAS:528:DC%2BC3sXht1Crsb7P, PID: 23624851
    • Morse MA, Chaudhry A, Gabitzsch ES, Hobeika AC, Osada T, Clay TM, et al. Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients. Cancer Immunol Immunother. 2013;62(8):1293–301.
    • (2013) Cancer Immunol Immunother , vol.62 , Issue.8 , pp. 1293-1301
    • Morse, M.A.1    Chaudhry, A.2    Gabitzsch, E.S.3    Hobeika, A.C.4    Osada, T.5    Clay, T.M.6
  • 138
    • 0027512782 scopus 로고
    • Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial
    • PID: 8445413
    • Hoover Jr HC, Brandhorst JS, Peters LC, Surdyke MG, Takeshita Y, Madariaga J, et al. Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial. J Clin Oncol. 1993;11(3):390–9.
    • (1993) J Clin Oncol , vol.11 , Issue.3 , pp. 390-399
    • Hoover, H.C.1    Brandhorst, J.S.2    Peters, L.C.3    Surdyke, M.G.4    Takeshita, Y.5    Madariaga, J.6
  • 139
    • 0033616482 scopus 로고    scopus 로고
    • Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
    • COI: 1:STN:280:DyaK1M7jtl2gtQ%3D%3D, PID: 9950438
    • Vermorken JB, Claessen AM, van Tinteren H, Gall HE, Ezinga R, Meijer S, et al. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet. 1999;353(9150):345–50.
    • (1999) Lancet , vol.353 , Issue.9150 , pp. 345-350
    • Vermorken, J.B.1    Claessen, A.M.2    van Tinteren, H.3    Gall, H.E.4    Ezinga, R.5    Meijer, S.6
  • 140
    • 0026744022 scopus 로고
    • Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trial
    • COI: 1:STN:280:DyaK3s%2FgvVWhtQ%3D%3D, PID: 1394336
    • Schlag P, Manasterski M, Gerneth T, Hohenberger P, Dueck M, Herfarth C, et al. Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trial. Cancer Immunol Immunother. 1992;35(5):325–30.
    • (1992) Cancer Immunol Immunother , vol.35 , Issue.5 , pp. 325-330
    • Schlag, P.1    Manasterski, M.2    Gerneth, T.3    Hohenberger, P.4    Dueck, M.5    Herfarth, C.6
  • 141
    • 54849420913 scopus 로고    scopus 로고
    • Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
    • COI: 1:CAS:528:DC%2BD1cXht1yqs7jE, PID: 18488223
    • Schulze T, Kemmner W, Weitz J, Wernecke KD, Schirrmacher V, Schlag PM. Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial. Cancer Immunol Immunother. 2009;58(1):61–9.
    • (2009) Cancer Immunol Immunother , vol.58 , Issue.1 , pp. 61-69
    • Schulze, T.1    Kemmner, W.2    Weitz, J.3    Wernecke, K.D.4    Schirrmacher, V.5    Schlag, P.M.6
  • 142
    • 0032055911 scopus 로고    scopus 로고
    • Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses
    • COI: 1:CAS:528:DyaK1cXitF2hsL0%3D, PID: 9516146
    • Osterborg A, Yi Q, Henriksson L, Fagerberg J, Bergenbrant S, Jeddi-Tehrani M, et al. Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses. Blood. 1998;91(7):2459–66.
    • (1998) Blood , vol.91 , Issue.7 , pp. 2459-2466
    • Osterborg, A.1    Yi, Q.2    Henriksson, L.3    Fagerberg, J.4    Bergenbrant, S.5    Jeddi-Tehrani, M.6
  • 143
    • 0031771557 scopus 로고    scopus 로고
    • Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen
    • COI: 1:CAS:528:DyaK1MXitVWl, PID: 9829838
    • Samanci A, Yi Q, Fagerberg J, Strigard K, Smith G, Ruden U, et al. Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen. Cancer Immunol Immunother. 1998;47(3):131–42.
    • (1998) Cancer Immunol Immunother , vol.47 , Issue.3 , pp. 131-142
    • Samanci, A.1    Yi, Q.2    Fagerberg, J.3    Strigard, K.4    Smith, G.5    Ruden, U.6
  • 144
    • 0037966117 scopus 로고    scopus 로고
    • Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony-stimulating factor induced a tumor-specific cellular immune response
    • COI: 1:CAS:528:DC%2BD3sXlt1ykurk%3D, PID: 12855617
    • Ullenhag GJ, Frodin JE, Mosolits S, Kiaii S, Hassan M, Bonnet MC, et al. Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony-stimulating factor induced a tumor-specific cellular immune response. Clin Cancer Res. 2003;9(7):2447–56.
    • (2003) Clin Cancer Res , vol.9 , Issue.7 , pp. 2447-2456
    • Ullenhag, G.J.1    Frodin, J.E.2    Mosolits, S.3    Kiaii, S.4    Hassan, M.5    Bonnet, M.C.6
  • 145
    • 13844294268 scopus 로고    scopus 로고
    • Colorectal cancer vaccines: what we know and what we don’t yet know
    • von Mehren M. Colorectal cancer vaccines: what we know and what we don’t yet know. Semin Oncol. 2005;32(1):76–84.
    • (2005) Semin Oncol , vol.32 , Issue.1 , pp. 76-84
    • von Mehren, M.1
  • 146
    • 0033017065 scopus 로고    scopus 로고
    • A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen
    • COI: 1:CAS:528:DyaK1MXkt1Oqurg%3D, PID: 10389916
    • Morse MA, Deng Y, Coleman D, Hull S, Kitrell-Fisher E, Nair S, et al. A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Clin Cancer Res. 1999;5(6):1331–8.
    • (1999) Clin Cancer Res , vol.5 , Issue.6 , pp. 1331-1338
    • Morse, M.A.1    Deng, Y.2    Coleman, D.3    Hull, S.4    Kitrell-Fisher, E.5    Nair, S.6
  • 147
    • 0035902607 scopus 로고    scopus 로고
    • Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
    • COI: 1:CAS:528:DC%2BD3MXls1Wiur4%3D, PID: 11427731
    • Fong L, Hou Y, Rivas A, Benike C, Yuen A, Fisher GA, et al. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci U S A. 2001;98(15):8809–14.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , Issue.15 , pp. 8809-8814
    • Fong, L.1    Hou, Y.2    Rivas, A.3    Benike, C.4    Yuen, A.5    Fisher, G.A.6
  • 148
    • 34748832351 scopus 로고    scopus 로고
    • Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides
    • COI: 1:CAS:528:DC%2BD2sXhtVOrtL7I, PID: 17893568
    • Kavanagh B, Ko A, Venook A, Margolin K, Zeh H, Lotze M, et al. Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides. J Immunother. 2007;30(7):762–72.
    • (2007) J Immunother , vol.30 , Issue.7 , pp. 762-772
    • Kavanagh, B.1    Ko, A.2    Venook, A.3    Margolin, K.4    Zeh, H.5    Lotze, M.6
  • 149
    • 27944451397 scopus 로고    scopus 로고
    • Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells
    • COI: 1:CAS:528:DC%2BD2MXht1GlsLbN, PID: 16034561
    • Babatz J, Rollig C, Lobel B, Folprecht G, Haack M, Gunther H, et al. Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells. Cancer Immunol Immunother. 2006;55(3):268–76.
    • (2006) Cancer Immunol Immunother , vol.55 , Issue.3 , pp. 268-276
    • Babatz, J.1    Rollig, C.2    Lobel, B.3    Folprecht, G.4    Haack, M.5    Gunther, H.6
  • 150
    • 11144355864 scopus 로고    scopus 로고
    • Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides
    • COI: 1:CAS:528:DC%2BD2cXjt1Clt7s%3D, PID: 15102666
    • Liu KJ, Wang CC, Chen LT, Cheng AL, Lin DT, Wu YC, et al. Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides. Clin Cancer Res. 2004;10(8):2645–51.
    • (2004) Clin Cancer Res , vol.10 , Issue.8 , pp. 2645-2651
    • Liu, K.J.1    Wang, C.C.2    Chen, L.T.3    Cheng, A.L.4    Lin, D.T.5    Wu, Y.C.6
  • 151
    • 0036124550 scopus 로고    scopus 로고
    • Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen
    • COI: 1:CAS:528:DC%2BD38XjvFSksrs%3D, PID: 11904734
    • Itoh T, Ueda Y, Kawashima I, Nukaya I, Fujiwara H, Fuji N, et al. Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen. Cancer Immunol Immunother. 2002;51(2):99–106.
    • (2002) Cancer Immunol Immunother , vol.51 , Issue.2 , pp. 99-106
    • Itoh, T.1    Ueda, Y.2    Kawashima, I.3    Nukaya, I.4    Fujiwara, H.5    Fuji, N.6
  • 152
    • 78049265321 scopus 로고    scopus 로고
    • A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
    • COI: 1:CAS:528:DC%2BC3cXhtlCjs7fP, PID: 20924373
    • Lesterhuis WJ, de Vries IJ, Aarntzen EA, de Boer A, Scharenborg NM, van de Rakt M, et al. A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients. Br J Cancer. 2010;103(9):1415–21.
    • (2010) Br J Cancer , vol.103 , Issue.9 , pp. 1415-1421
    • Lesterhuis, W.J.1    de Vries, I.J.2    Aarntzen, E.A.3    de Boer, A.4    Scharenborg, N.M.5    van de Rakt, M.6
  • 153
    • 78751504910 scopus 로고    scopus 로고
    • Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients
    • PID: 21187495
    • Lesterhuis WJ, De Vries IJ, Schreibelt G, Schuurhuis DH, Aarntzen EH, De Boer A, et al. Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients. Anticancer Res. 2010;30(12):5091–7.
    • (2010) Anticancer Res , vol.30 , Issue.12 , pp. 5091-5097
    • Lesterhuis, W.J.1    De Vries, I.J.2    Schreibelt, G.3    Schuurhuis, D.H.4    Aarntzen, E.H.5    De Boer, A.6
  • 154
    • 0033516548 scopus 로고    scopus 로고
    • Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA
    • COI: 1:CAS:528:DyaK1MXktVanu7c%3D, PID: 10360830
    • Nair SK, Hull S, Coleman D, Gilboa E, Lyerly HK, Morse MA. Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA. Int J Cancer. 1999;82(1):121–4.
    • (1999) Int J Cancer , vol.82 , Issue.1 , pp. 121-124
    • Nair, S.K.1    Hull, S.2    Coleman, D.3    Gilboa, E.4    Lyerly, H.K.5    Morse, M.A.6
  • 155
    • 34848837386 scopus 로고    scopus 로고
    • Taking dendritic cells into medicine
    • COI: 1:CAS:528:DC%2BD2sXhtV2is7%2FI, PID: 17898760
    • Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449(7161):419–26.
    • (2007) Nature , vol.449 , Issue.7161 , pp. 419-426
    • Steinman, R.M.1    Banchereau, J.2
  • 156
    • 84868216252 scopus 로고    scopus 로고
    • Combined TLR stimulation with Pam3Cys and poly I: C enhances Flt3-ligand dendritic cell activation for tumor immunotherapy
    • COI: 1:CAS:528:DC%2BC38XhsFGqt7jN, PID: 23090076
    • Lim SN, Kuhn S, Hyde E, Ronchese F. Combined TLR stimulation with Pam3Cys and poly I: C enhances Flt3-ligand dendritic cell activation for tumor immunotherapy. J Immunother. 2012;35(9):670–9.
    • (2012) J Immunother , vol.35 , Issue.9 , pp. 670-679
    • Lim, S.N.1    Kuhn, S.2    Hyde, E.3    Ronchese, F.4
  • 157
    • 84929938717 scopus 로고    scopus 로고
    • In vitro induction of potent tumor-specific cytotoxic T lymphocytes using TLR agonist-activated AML-DC
    • PID: 23852664
    • Nourizadeh M, Masoumi F, Memarian A, Alimoghaddam K, Moazzeni SM, Yaghmaie M, et al. In vitro induction of potent tumor-specific cytotoxic T lymphocytes using TLR agonist-activated AML-DC. Target Oncol. 2014;9(3):225–37.
    • (2014) Target Oncol , vol.9 , Issue.3 , pp. 225-237
    • Nourizadeh, M.1    Masoumi, F.2    Memarian, A.3    Alimoghaddam, K.4    Moazzeni, S.M.5    Yaghmaie, M.6
  • 158
    • 84877965360 scopus 로고    scopus 로고
    • Synergy between vitamin D(3) and toll-like receptor agonists regulates human dendritic cell response during maturation
    • PID: 23710204
    • Brosbol-Ravnborg A, Bundgaard B, Hollsberg P. Synergy between vitamin D(3) and toll-like receptor agonists regulates human dendritic cell response during maturation. Clin Dev Immunol. 2013;2013:807971.
    • (2013) Clin Dev Immunol , vol.2013 , pp. 807971
    • Brosbol-Ravnborg, A.1    Bundgaard, B.2    Hollsberg, P.3
  • 159
    • 20244383301 scopus 로고    scopus 로고
    • Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules
    • COI: 1:CAS:528:DC%2BD2MXjtlejtLk%3D, PID: 15837756
    • Morse MA, Clay TM, Hobeika AC, Osada T, Khan S, Chui S, et al. Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules. Clin Cancer Res. 2005;11(8):3017–24.
    • (2005) Clin Cancer Res , vol.11 , Issue.8 , pp. 3017-3024
    • Morse, M.A.1    Clay, T.M.2    Hobeika, A.C.3    Osada, T.4    Khan, S.5    Chui, S.6
  • 160
    • 77951086882 scopus 로고    scopus 로고
    • 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity
    • COI: 1:CAS:528:DC%2BC3cXkslShsLk%3D, PID: 20388795
    • Vincent J, Mignot G, Chalmin F, Ladoire S, Bruchard M, Chevriaux A, et al. 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res. 2010;70(8):3052–61.
    • (2010) Cancer Res , vol.70 , Issue.8 , pp. 3052-3061
    • Vincent, J.1    Mignot, G.2    Chalmin, F.3    Ladoire, S.4    Bruchard, M.5    Chevriaux, A.6
  • 161
    • 77954187741 scopus 로고    scopus 로고
    • DNA topoisomerases and their poisoning by anticancer and antibacterial drugs
    • COI: 1:CAS:528:DC%2BC3cXmslCjsLY%3D, PID: 20534341
    • Pommier Y, Leo E, Zhang H, Marchand C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol. 2010;17(5):421–33.
    • (2010) Chem Biol , vol.17 , Issue.5 , pp. 421-433
    • Pommier, Y.1    Leo, E.2    Zhang, H.3    Marchand, C.4
  • 162
    • 84909608106 scopus 로고    scopus 로고
    • Adverse immunoregulatory effects of 5FU and CPT11 chemotherapy on myeloid-derived suppressor cells and colorectal cancer outcomes
    • COI: 1:CAS:528:DC%2BC2cXhvVGjtLfK, PID: 25209187, The authors demonstrate that CP11 encourages detrimental immune regulation that counters the benefits of 5FU
    • Kanterman J, Sade-Feldman M, Biton M, Ish-Shalom E, Lasry A, Goldshtein A, et al. Adverse immunoregulatory effects of 5FU and CPT11 chemotherapy on myeloid-derived suppressor cells and colorectal cancer outcomes. Cancer Res. 2014;74(21):6022–35. The authors demonstrate that CP11 encourages detrimental immune regulation that counters the benefits of 5FU.
    • (2014) Cancer Res , vol.74 , Issue.21 , pp. 6022-6035
    • Kanterman, J.1    Sade-Feldman, M.2    Biton, M.3    Ish-Shalom, E.4    Lasry, A.5    Goldshtein, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.